CIDRAP2d
Estimates: Jynneos mpox vaccine 84% and 35% effective in people without, with HIV
One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...
Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% ...
Physician's Weekly22h
Mpox Protection and Safety of MVA-BN Vaccination
The following is a summary of “Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany ...
Science Daily1d
New data on Mpox vaccine effectiveness
A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...
Health officials urge parents to vaccinate their children as measles outbreak spreads to Ohio
An outbreak of measles that has been spreading across the country has reached Ohio. Health officials say that an unvaccinated ...
CDC to Re-Investigate Vaccines and Autism, Despite Decades of Evidence Showing No Link
Under the new leadership of Robert F. Kennedy Jr., the CDC is expected to look into a long-debunked connection between ...
Are COVID-19 Vaccines Safe and Effective?
Initial phase III trial results from November 2020 suggested that, after two doses, new mRNA vaccines developed by Moderna ...
NCLA Asks en Banc Ninth Circuit to Allow Suit Against Vaccine Mandate that Did Not Stop the Spread
The New Civil Liberties Alliance filed an amicus curiae brief today urging the en banc U.S. Court of Appeals for the Ninth Circuit to allow the Plaintiffs’ lawsuit in Health Freedom Defense Fund v.